October 11 | 6 Strong Buy Health Technology Stocks On Watchlist

This is a must read ["We need batteries. Literally everywhere."]( [Read about this company's once-in-a-lifetime graphite opportunity -- before Wall Street]( --------------------------------------------------------------- Dear Reader, We have identified 6 'Strong Buy' Health Technology Trade Stocks that you might want to keep an eye on....Keep in mind, these are very volatile stocks so please do your own research before you make any investments. We are not recommending these stocks but they are certainly getting positive attention from analysts. --------------------------------------------------------------- [Far Beyond EVs]( may have grabbed the headlines as a key material in building electric vehicles (EVs). But so is copper. And copper's importance in the new green economy goes far beyond EVs. Copper is critical in building wind turbines and solar panels. It's key to power lines and upgrading the national grid. Analysts say we're facing a 10-million-ton shortfall if new copper mines are not found. [See How You Can Benefit From New Copper Discoveries.]() --------------------------------------------------------------- See the list below. [Merck & Company, MRK](=) - Buy to Strong Buy [TipRanks.com]() also reports that [Merck & Company]( currently has 13 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $101.36. The target pricing ranges from a high forecast of $116.00 down to a low forecast of $91.00. [Merck & Company (MRK)](’s last closing price was $90.4 which would put the average price target at 11.53% upside. Based on 3rd party rating services including: - TipRanks.com: Strong Buy - TradingView.com: Strong Buy Our research team shows Yahoo! Finance with a Bullish Short-Term Outlook and Barchart.com with a buy rating. [Click for chart >>]( = ----------------------------------------------------- [Dice Therapeutics, DICE](=) - Buy to Strong Buy [TipRanks.com]( also reports that [Dice Therapeutics](=) currently has 4 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $39.75. The target pricing ranges from a high forecast of $46.00 down to a low forecast of $36.00. [Dice Therapeutics (DICE)](=)’s last closing price was $38.15 which would put the average price target at 4.19% upside. Based on 3rd party rating services including: - TipRanks.com: Strong Buy - TradingView.com: Strong Buy Our research team shows Yahoo! Finance with a Bullish Short-Term Outlook and Barchart.com with a Strong buy rating. [Click for chart >>]() = ----------------------------------------------------- --------------------------------------------------------------- Market Wizard who predicted all indexes would be negative in 2022 shares shocking new forecast: ["Prepare for Five Years of Famine"]() = [Click here]( for the name of the one ticker you need to protect yourself. --------------------------------------------------------------- [Pliant Therapeutics, PLRX]() - Buy to Strong Buy [TipRanks.com]() also reports that [Pliant Therapeutics]() currently has 9 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $43.00. The target pricing ranges from a high forecast of $53.00 down to a low forecast of $36.00. [Pliant Therapeutics (PLRX)]()’s last closing price was $22.46 which would put the average price target at 91.45% upside. Based on 3rd party rating services including: - TipRanks.com: Strong Buy - TradingView.com: Strong Buy Our research team shows Yahoo! Finance with a Bullish Short-Term Outlook and Barchart.com with a Strong buy rating. [Click for chart >>]( ----------------------------------------------------- [Minerva Neurosciences, NERV]() - Buy to Strong Buy [TipRanks.com](=) also reports that [Minerva Neurosciences]() currently has 3 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $17.00. The target pricing ranges from a high forecast of $24.00 down to a low forecast of $6.00. [Minerva Neurosciences (NERV)]()’s last closing price was $10.73 which would put the average price target at 58.43% upside. Based on 3rd party rating services including: - TipRanks.com: Strong Buy - TradingView.com: Buy Our research team shows Yahoo! Finance with a Bullish Short-Term Outlook and Barchart.com with a Strong buy rating. [Click for chart >>](=) ----------------------------------------------------- --------------------------------------------------------------- ["TAKE THAT, CHINA!" USA Gains in EV Battery Arms Race]( you know each electric car battery requires 220 pounds of graphite ñ more than lithium, copper, or aluminum? China enjoyed a "near monopoly" in this vital ingredient... until the U.S. made a blockbuster announcement. Now one little-known company is set to play a crucial role in the booming $7 trillion EV revolution. [Get the full story on this new North American graphite opportunity]( --------------------------------------------------------------- [IVERIC bio, ISEE](=) - Buy to Strong Buy [TipRanks.com]() also reports that [IVERIC bio](=) currently has 9 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $27.22. The target pricing ranges from a high forecast of $35.00 down to a low forecast of $8.00. [IVERIC bio (ISEE)]()’s last closing price was $19.86 which would put the average price target at 37.06% upside. Based on 3rd party rating services including: - TipRanks.com: Strong Buy - TradingView.com: Buy Our research team shows Yahoo! Finance with a Neutral Short-Term Outlook and Barchart.com with a Strong buy rating. [Click for chart >>](=) = ----------------------------------------------------- [Logicbio Therapeutics, LOGC](=) - Buy to Strong Buy [TipRanks.com]() also reports that [Logicbio Therapeutics]() currently has 3 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $2.50. The target pricing ranges from a high forecast of $2.50 down to a low forecast of $2.50. [Logicbio Therapeutics (LOGC)](=)’s last closing price was $2.035 which would put the average price target at 22.85% upside. Based on 3rd party rating services including: - TipRanks.com: Moderate Buy - TradingView.com: Strong Buy Our research team shows Yahoo! Finance with a Bullish Short-Term Outlook and Barchart.com with a Strong buy rating. [Click for chart >>](=) = ----------------------------------------------------- Pricing & Percentages as of approximately 10:00am EST. [TipRanks.com]() tracks and measures the performance of over 50,000 financial experts. The TipRanks Star Ranking TM is calculated based on expert success rate, average return and statistical significance. [Get more from TipRanks.com here >>]( --------------------------------------------------------------- [A $226B Copper Spending Jackpot]( November 15, 2021, President Biden signed the biggest infrastructure spending bill of all time. A staggering $226 BILLION is earmarked for projects requiring huge amounts of copper. Turns out, copper is a desperately needed mineral to power the green revolution of clean, renewable energy. [See Who Can Benefit From this Government-backed Initiative.]() --------------------------------------------------------------- [Unsubscribe]( Sandpiper Marketing Group, LLC PO Box 407 Mt. Mourne, North Carolina 28123 United States (845) 803-0954 If you no longer wish to receive our emails, click the link below: [Unsubscribe]( MarketSectorDaily.com part of Sandpiper Marketing Group, LLC 165 Lockerbie Lane Mooresville, North Carolina 28115 United States (877) 411-9808